Report Overview
This report provides a deep insight into the global Inactivated Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inactivated Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inactivated Influenza Vaccine market in any manner.
Global Inactivated Influenza Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Changchun Institute of Biological
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
Children
Adolescence
Adults
Elderly
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Inactivated Influenza Vaccine Market
? Overview of the regional outlook of the Inactivated Influenza Vaccine Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Inactivated Influenza Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Vaccine Segment by Type
1.2.2 Inactivated Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Inactivated Influenza Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Inactivated Influenza Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Inactivated Influenza Vaccine Market Competitive Landscape
3.1 Global Inactivated Influenza Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Inactivated Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Inactivated Influenza Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Inactivated Influenza Vaccine Sales Sites, Area Served, Product Type
3.6 Inactivated Influenza Vaccine Market Competitive Situation and Trends
3.6.1 Inactivated Influenza Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Inactivated Influenza Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Inactivated Influenza Vaccine Industry Chain Analysis
4.1 Inactivated Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Inactivated Influenza Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Inactivated Influenza Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Inactivated Influenza Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Inactivated Influenza Vaccine Price by Type (2019-2024)
7 Inactivated Influenza Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Vaccine Market Sales by Application (2019-2024)
7.3 Global Inactivated Influenza Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2019-2024)
8 Inactivated Influenza Vaccine Market Segmentation by Region
8.1 Global Inactivated Influenza Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Inactivated Influenza Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Inactivated Influenza Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Inactivated Influenza Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Inactivated Influenza Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Inactivated Influenza Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CSL Limited
9.1.1 CSL Limited Inactivated Influenza Vaccine Basic Information
9.1.2 CSL Limited Inactivated Influenza Vaccine Product Overview
9.1.3 CSL Limited Inactivated Influenza Vaccine Product Market Performance
9.1.4 CSL Limited Business Overview
9.1.5 CSL Limited Inactivated Influenza Vaccine SWOT Analysis
9.1.6 CSL Limited Recent Developments
9.2 GSK
9.2.1 GSK Inactivated Influenza Vaccine Basic Information
9.2.2 GSK Inactivated Influenza Vaccine Product Overview
9.2.3 GSK Inactivated Influenza Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Inactivated Influenza Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Inactivated Influenza Vaccine Basic Information
9.3.2 Sanofi Pasteur Inactivated Influenza Vaccine Product Overview
9.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Product Market Performance
9.3.4 Sanofi Pasteur Inactivated Influenza Vaccine SWOT Analysis
9.3.5 Sanofi Pasteur Business Overview
9.3.6 Sanofi Pasteur Recent Developments
9.4 Viatris
9.4.1 Viatris Inactivated Influenza Vaccine Basic Information
9.4.2 Viatris Inactivated Influenza Vaccine Product Overview
9.4.3 Viatris Inactivated Influenza Vaccine Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 Hualan Biological
9.5.1 Hualan Biological Inactivated Influenza Vaccine Basic Information
9.5.2 Hualan Biological Inactivated Influenza Vaccine Product Overview
9.5.3 Hualan Biological Inactivated Influenza Vaccine Product Market Performance
9.5.4 Hualan Biological Business Overview
9.5.5 Hualan Biological Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Inactivated Influenza Vaccine Basic Information
9.6.2 AstraZeneca Inactivated Influenza Vaccine Product Overview
9.6.3 AstraZeneca Inactivated Influenza Vaccine Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Sinovac Biotech
9.7.1 Sinovac Biotech Inactivated Influenza Vaccine Basic Information
9.7.2 Sinovac Biotech Inactivated Influenza Vaccine Product Overview
9.7.3 Sinovac Biotech Inactivated Influenza Vaccine Product Market Performance
9.7.4 Sinovac Biotech Business Overview
9.7.5 Sinovac Biotech Recent Developments
9.8 Aleph Biomedical
9.8.1 Aleph Biomedical Inactivated Influenza Vaccine Basic Information
9.8.2 Aleph Biomedical Inactivated Influenza Vaccine Product Overview
9.8.3 Aleph Biomedical Inactivated Influenza Vaccine Product Market Performance
9.8.4 Aleph Biomedical Business Overview
9.8.5 Aleph Biomedical Recent Developments
9.9 Abbott Laboratories
9.9.1 Abbott Laboratories Inactivated Influenza Vaccine Basic Information
9.9.2 Abbott Laboratories Inactivated Influenza Vaccine Product Overview
9.9.3 Abbott Laboratories Inactivated Influenza Vaccine Product Market Performance
9.9.4 Abbott Laboratories Business Overview
9.9.5 Abbott Laboratories Recent Developments
9.10 Novartis International
9.10.1 Novartis International Inactivated Influenza Vaccine Basic Information
9.10.2 Novartis International Inactivated Influenza Vaccine Product Overview
9.10.3 Novartis International Inactivated Influenza Vaccine Product Market Performance
9.10.4 Novartis International Business Overview
9.10.5 Novartis International Recent Developments
9.11 Changchun Institute of Biological
9.11.1 Changchun Institute of Biological Inactivated Influenza Vaccine Basic Information
9.11.2 Changchun Institute of Biological Inactivated Influenza Vaccine Product Overview
9.11.3 Changchun Institute of Biological Inactivated Influenza Vaccine Product Market Performance
9.11.4 Changchun Institute of Biological Business Overview
9.11.5 Changchun Institute of Biological Recent Developments
9.12 BCHT
9.12.1 BCHT Inactivated Influenza Vaccine Basic Information
9.12.2 BCHT Inactivated Influenza Vaccine Product Overview
9.12.3 BCHT Inactivated Influenza Vaccine Product Market Performance
9.12.4 BCHT Business Overview
9.12.5 BCHT Recent Developments
9.13 Jiangsu GDK
9.13.1 Jiangsu GDK Inactivated Influenza Vaccine Basic Information
9.13.2 Jiangsu GDK Inactivated Influenza Vaccine Product Overview
9.13.3 Jiangsu GDK Inactivated Influenza Vaccine Product Market Performance
9.13.4 Jiangsu GDK Business Overview
9.13.5 Jiangsu GDK Recent Developments
9.14 KM Biologics
9.14.1 KM Biologics Inactivated Influenza Vaccine Basic Information
9.14.2 KM Biologics Inactivated Influenza Vaccine Product Overview
9.14.3 KM Biologics Inactivated Influenza Vaccine Product Market Performance
9.14.4 KM Biologics Business Overview
9.14.5 KM Biologics Recent Developments
10 Inactivated Influenza Vaccine Market Forecast by Region
10.1 Global Inactivated Influenza Vaccine Market Size Forecast
10.2 Global Inactivated Influenza Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Inactivated Influenza Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Inactivated Influenza Vaccine Market Size Forecast by Region
10.2.4 South America Inactivated Influenza Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Inactivated Influenza Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Inactivated Influenza Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Inactivated Influenza Vaccine by Type (2025-2030)
11.1.2 Global Inactivated Influenza Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Inactivated Influenza Vaccine by Type (2025-2030)
11.2 Global Inactivated Influenza Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Inactivated Influenza Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Inactivated Influenza Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inactivated Influenza Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Inactivated Influenza Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Inactivated Influenza Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2022)
Table 10. Global Market Inactivated Influenza Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Inactivated Influenza Vaccine Sales Sites and Area Served
Table 12. Manufacturers Inactivated Influenza Vaccine Product Type
Table 13. Global Inactivated Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Inactivated Influenza Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Influenza Vaccine Market Challenges
Table 22. Global Inactivated Influenza Vaccine Sales by Type (Kilotons)
Table 23. Global Inactivated Influenza Vaccine Market Size by Type (M USD)
Table 24. Global Inactivated Influenza Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Inactivated Influenza Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Inactivated Influenza Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Inactivated Influenza Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Inactivated Influenza Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Inactivated Influenza Vaccine Sales (Kilotons) by Application
Table 30. Global Inactivated Influenza Vaccine Market Size by Application
Table 31. Global Inactivated Influenza Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Inactivated Influenza Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Inactivated Influenza Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Inactivated Influenza Vaccine Market Share by Application (2019-2024)
Table 35. Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Inactivated Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Inactivated Influenza Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Inactivated Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Inactivated Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Inactivated Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Inactivated Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Limited Inactivated Influenza Vaccine Basic Information
Table 44. CSL Limited Inactivated Influenza Vaccine Product Overview
Table 45. CSL Limited Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Limited Business Overview
Table 47. CSL Limited Inactivated Influenza Vaccine SWOT Analysis
Table 48. CSL Limited Recent Developments
Table 49. GSK Inactivated Influenza Vaccine Basic Information
Table 50. GSK Inactivated Influenza Vaccine Product Overview
Table 51. GSK Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Inactivated Influenza Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Pasteur Inactivated Influenza Vaccine Basic Information
Table 56. Sanofi Pasteur Inactivated Influenza Vaccine Product Overview
Table 57. Sanofi Pasteur Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Pasteur Inactivated Influenza Vaccine SWOT Analysis
Table 59. Sanofi Pasteur Business Overview
Table 60. Sanofi Pasteur Recent Developments
Table 61. Viatris Inactivated Influenza Vaccine Basic Information
Table 62. Viatris Inactivated Influenza Vaccine Product Overview
Table 63. Viatris Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. Hualan Biological Inactivated Influenza Vaccine Basic Information
Table 67. Hualan Biological Inactivated Influenza Vaccine Product Overview
Table 68. Hualan Biological Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Hualan Biological Business Overview
Table 70. Hualan Biological Recent Developments
Table 71. AstraZeneca Inactivated Influenza Vaccine Basic Information
Table 72. AstraZeneca Inactivated Influenza Vaccine Product Overview
Table 73. AstraZeneca Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Sinovac Biotech Inactivated Influenza Vaccine Basic Information
Table 77. Sinovac Biotech Inactivated Influenza Vaccine Product Overview
Table 78. Sinovac Biotech Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Sinovac Biotech Business Overview
Table 80. Sinovac Biotech Recent Developments
Table 81. Aleph Biomedical Inactivated Influenza Vaccine Basic Information
Table 82. Aleph Biomedical Inactivated Influenza Vaccine Product Overview
Table 83. Aleph Biomedical Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Aleph Biomedical Business Overview
Table 85. Aleph Biomedical Recent Developments
Table 86. Abbott Laboratories Inactivated Influenza Vaccine Basic Information
Table 87. Abbott Laboratories Inactivated Influenza Vaccine Product Overview
Table 88. Abbott Laboratories Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Abbott Laboratories Business Overview
Table 90. Abbott Laboratories Recent Developments
Table 91. Novartis International Inactivated Influenza Vaccine Basic Information
Table 92. Novartis International Inactivated Influenza Vaccine Product Overview
Table 93. Novartis International Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Novartis International Business Overview
Table 95. Novartis International Recent Developments
Table 96. Changchun Institute of Biological Inactivated Influenza Vaccine Basic Information
Table 97. Changchun Institute of Biological Inactivated Influenza Vaccine Product Overview
Table 98. Changchun Institute of Biological Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Changchun Institute of Biological Business Overview
Table 100. Changchun Institute of Biological Recent Developments
Table 101. BCHT Inactivated Influenza Vaccine Basic Information
Table 102. BCHT Inactivated Influenza Vaccine Product Overview
Table 103. BCHT Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BCHT Business Overview
Table 105. BCHT Recent Developments
Table 106. Jiangsu GDK Inactivated Influenza Vaccine Basic Information
Table 107. Jiangsu GDK Inactivated Influenza Vaccine Product Overview
Table 108. Jiangsu GDK Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Jiangsu GDK Business Overview
Table 110. Jiangsu GDK Recent Developments
Table 111. KM Biologics Inactivated Influenza Vaccine Basic Information
Table 112. KM Biologics Inactivated Influenza Vaccine Product Overview
Table 113. KM Biologics Inactivated Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. KM Biologics Business Overview
Table 115. KM Biologics Recent Developments
Table 116. Global Inactivated Influenza Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Inactivated Influenza Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Inactivated Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Inactivated Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Inactivated Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Inactivated Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Inactivated Influenza Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Inactivated Influenza Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Inactivated Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Inactivated Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Inactivated Influenza Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Inactivated Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Inactivated Influenza Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Inactivated Influenza Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Inactivated Influenza Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Inactivated Influenza Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Inactivated Influenza Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Inactivated Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Inactivated Influenza Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Inactivated Influenza Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Vaccine Market Size by Country (M USD)
Figure 11. Inactivated Influenza Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Inactivated Influenza Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Inactivated Influenza Vaccine Market Share by Type
Figure 18. Sales Market Share of Inactivated Influenza Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Inactivated Influenza Vaccine by Type in 2023
Figure 20. Market Size Share of Inactivated Influenza Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Inactivated Influenza Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Inactivated Influenza Vaccine Market Share by Application
Figure 24. Global Inactivated Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Inactivated Influenza Vaccine Sales Market Share by Application in 2023
Figure 26. Global Inactivated Influenza Vaccine Market Share by Application (2019-2024)
Figure 27. Global Inactivated Influenza Vaccine Market Share by Application in 2023
Figure 28. Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Inactivated Influenza Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Inactivated Influenza Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Inactivated Influenza Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Inactivated Influenza Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Inactivated Influenza Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Inactivated Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Inactivated Influenza Vaccine Sales Market Share by Region in 2023
Figure 44. China Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Inactivated Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Inactivated Influenza Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Inactivated Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Inactivated Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Inactivated Influenza Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Inactivated Influenza Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Inactivated Influenza Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Inactivated Influenza Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Inactivated Influenza Vaccine Market Share Forecast by Application (2025-2030)
